Sources Used in Current Review
Sources Used in Previous Reviews
Mayo 2001 Test Catalog, Mayo Medical Laboratories, Rochester, MN, 2000 Mayo Press.
Riley, T (1 November 2001). Preventieve strategieën bij chronische leverziekte: deel I. Alcohol, vaccins, giftige medicijnen en supplementen, dieet en lichaamsbeweging. American Family Physician: American Academy of Family Physicians. Online beschikbaar op http://www.aafp.org/afp/20011101/1555.html.Thomas, Clayton L., Editor (1997)., Taber ‘ s Cyclopedic Medical Dictionary. F. A. Davis Company, Philadelphia, PA .
Dufour DR, et al. Diagnose en controle van leverbeschadiging – I. kenmerken van laboratoriumtests. Clin Chem 2000; 46: 2027-2049.
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER en Bruns de, eds. 4e ed. St. Louis, Missouri: Elsevier Saunders; 2006 Pg 613.
Pagana K, Pagana T. Mosby ‘ s Manual of Diagnostic and Laboratory Tests. 3rd Edition, St. Louis: Mosby Elsevier; 2006, Pp. 259-260.
Clarke, W. and Dufour, D. R., Editors (2006)., Hedendaagse praktijk in de Klinische Chemie. AACC Press, Washington, DC, Pg. 271.
Henry ‘ s klinische diagnose en behandeling volgens laboratoriummethoden. 21st ed. McPherson RA en Pincus MR, eds. Philadelphia: 2007, Pp 86, 275.
(2000) Dufour, DR et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Laboratoriumrichtlijnen voor Screening, diagnose en Monitoring van leverbeschadiging. Online beschikbaar op http://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/hepatic/hepatic_combined.pdf#page=3.
Kim, KM et al. (Augustus., 2012) Serum gamma-glutamyltransferase as a risk factor for general cardiovascular disease prediction in Koreans. National Center for Biotechnology Information PubMed database. Available online at http://www.ncbi.nlm.nih.gov/pubmed/23138005. Accessed September 2013.